Christof Scheid Selected Research

posaconazole

10/2021

Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christof Scheid Research Topics

Disease

38	Multiple Myeloma 12/2024 - 02/2006
23	Neoplasms (Cancer) 05/2024 - 10/2002
15	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 03/2004
13	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 12/2009
12	Infections 05/2024 - 02/2011
12	Lymphoma (Lymphomas) 04/2024 - 02/2011
10	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2024 - 12/2002
9	Leukemia 01/2021 - 03/2004
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 10/2010
4	Disease Progression 01/2020 - 03/2004
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2022 - 04/2018
3	Bronchiolitis Obliterans Syndrome 12/2022 - 01/2019
3	Viremia 01/2020 - 08/2017
3	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 02/2013
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 10/2010
3	Neutropenia 02/2015 - 03/2004
2	Colitis 02/2024 - 01/2016
2	Septic Shock (Toxic Shock Syndrome) 02/2024 - 11/2022
2	Residual Neoplasm 09/2023 - 11/2022
2	Primary Myelofibrosis (Myelosclerosis) 07/2023 - 04/2021
2	Inflammation (Inflammations) 04/2021 - 01/2017
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2018 - 01/2012
2	Hematologic Diseases (Blood Diseases) 10/2017 - 12/2009
2	Peripheral Nervous System Diseases (PNS Diseases) 12/2016 - 07/2015
2	Autoimmune Diseases (Autoimmune Disease) 11/2014 - 10/2002
2	Infarction (Infarctions) 05/2012 - 07/2006
2	Fever (Fevers) 02/2012 - 03/2004
2	Thrombotic Thrombocytopenic Purpura 10/2010 - 10/2002
1	VEXAS syndrome 02/2024
1	Cytokine Release Syndrome 02/2024
1	Pneumonia (Pneumonitis) 02/2024
1	Pulmonary Embolism 02/2024
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2024
1	Meningoencephalitis 02/2024
1	Sepsis (Septicemia) 02/2024
1	Paraproteinemias (Monoclonal Gammopathy) 01/2023
1	Multiple Sclerosis 01/2023
1	Renal Insufficiency (Renal Failure) 11/2022
1	Enteritis 11/2022
1	Heart Arrest (Cardiac Arrest) 11/2022
1	Bacterial Infections (Bacterial Infection) 06/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

11	Bortezomib (Velcade)FDA Link 02/2024 - 01/2012
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2024 - 01/2012
9	Dexamethasone (Maxidex)FDA LinkGeneric 02/2024 - 06/2012
8	Lenalidomide (CC 5013)FDA Link 02/2024 - 04/2016
6	Monoclonal AntibodiesIBA 05/2024 - 10/2002
6	Melphalan (Alkeran)FDA LinkGeneric 11/2022 - 01/2016
5	Busulfan (Busulfex)FDA Link 01/2022 - 01/2016
4	treosulfanIBA 01/2022 - 01/2012
4	fludarabineIBA 01/2020 - 01/2016
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 02/2006
3	ibrutinibIBA 02/2024 - 01/2019
3	Rituximab (Mabthera)FDA Link 01/2020 - 10/2002
3	Thalidomide (Thalomid)FDA Link 11/2019 - 01/2008
3	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 10/2010
3	Brentuximab VedotinIBA 01/2019 - 02/2013
2	Everolimus FDA Link 04/2024 - 01/2021
2	isatuximabIBA 09/2023 - 11/2022
2	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 08/2017
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 07/2013
2	Ophthalmic Solutions (Eye Drops)IBA 01/2021 - 01/2017
2	Sorafenib (BAY 43-9006)FDA Link 04/2018 - 01/2018
2	Interleukin-15 (Interleukin 15)IBA 04/2018 - 01/2018
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 10/2013 - 09/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 02/2012 - 02/2011
2	thiamine triphosphorate (TTP)IBA 10/2010 - 10/2002
1	Immunoglobulins (Immunoglobulin)IBA 12/2024
1	cytomegalovirus-specific hyperimmune globulinIBA 12/2024
1	daratumumabIBA 05/2024
1	Antineoplastic Agents (Antineoplastics)IBA 05/2024
1	Glycoproteins (Glycoprotein)IBA 05/2024
1	Calcineurin InhibitorsIBA 04/2024
1	tocilizumab (atlizumab)FDA Link 02/2024
1	elotuzumabIBA 02/2024
1	carfilzomibIBA 09/2023
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 07/2023
1	encorafenibIBA 01/2023
1	binimetinibIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	cyclo(Arg-Pro) (CI 4)IBA 06/2022
1	Immunomodulating AgentsIBA 01/2022

Therapy/Procedure

36	Stem Cell Transplantation 02/2024 - 10/2010
29	Therapeutics 05/2024 - 12/2002
18	Hematopoietic Stem Cell Transplantation 12/2022 - 12/2009
15	Cell Transplantation 02/2024 - 10/2017
11	Transplantation 05/2024 - 12/2009
7	Drug Therapy (Chemotherapy) 01/2022 - 12/2002
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 04/2024 - 02/2012
3	Autologous Transplantation 01/2018 - 01/2016
3	Homologous Transplantation 07/2017 - 04/2013
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2016 - 03/2004
2	Salvage Therapy 01/2022 - 01/2020
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2012 - 07/2006
2	Injections 05/2012 - 07/2006
2	Plasma Exchange 10/2010 - 10/2002
1	Immunotherapy 06/2022